Evaluation of cardiac findings in mucopolysaccharidosis

被引:2
|
作者
Dehghan, Bahar [1 ]
Rostampour, Noushin [2 ]
Sedighi, Mohsen [3 ]
Saryazdi, Mohammad Hosseini [4 ]
Rizi, Mohammad Jokar [4 ]
Mostofizadeh, Neda [2 ]
Hashemipour, Mahin [2 ]
Khoshhali, Mehri [5 ]
机构
[1] Isfahan Univ Med Sci, Cardiovasc Res Inst, Pediat Cardiovasc Res Ctr, Esfahan, Iran
[2] Isfahan Univ Med Sci, Metab Liver Dis Res Ctr, Esfahan, Iran
[3] Iran Univ Med Sci, Trauma & Injury Res Ctr, Tehran, Iran
[4] Isfahan Univ Med Sci, Sch Med, Esfahan, Iran
[5] Isfahan Univ Med Sci, Child Growth & Dev Res Ctr, Esfahan, Iran
关键词
Mucopolysaccharidoses; Children; Heart; Echocardiography; ENZYME-REPLACEMENT THERAPY; INVOLVEMENT; MORTALITY; CHILDREN;
D O I
10.1007/s10554-023-02983-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose Mucopolysaccharidoses (MPS) are a group of rare genetic diseases and heart involvement is one of the important conflicts in most types, which may cause serious complications. We used M-Mode and two-dimensional speckle tracking echocardiography (2D-STE) to explore cardiovascular involvements in MPS patients.Method The present cross-sectional study investigated the frequency of cardiac involvements in MPS patients. Included participants were MPS types I, II, III, IV, and VI who underwent specialized echocardiography exams to assess valvular function, systolic and diastolic function, left ventricular ejection fraction (LVEF), and global longitudinal strain (GLS).Results 35 patients were enrolled in this study. The total mean age of patients was 9.58 +/- 5.11 years and 71.4% were male. Type IV (40%) and type III (31.4%) were the most frequent MPS. Although LVEF did not differ notably among MPS types, GLS was significantly different (p = 0.029). Mitral regurgitation was observed remarkably more in MPS type III (p = 0.001) while mitral stenosis was more common in type III (p = 0.007). There was a significant association between LVEF and GLS (beta= -0.662; p = 0.025) and between LVEF and MPS type (beta = 1.82; p = 0.025) when adjusted for GLS.Conclusion Cardiac complications are very common and are one of the most important causes of death in MPS patients. 2D-STE seems to be superior to M-Mode for detection of early and subclinical cardiac dysfunction in MPS patients.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [31] Tracheobronchial stents in mucopolysaccharidosis
    Karl, Reiter
    Carola, Schoen
    Regina, Ensenauer
    Thomas, Nicolai
    Huber, Rudolf M.
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2016, 83 (04) : 187 - 192
  • [32] Evaluation of histopathological findings of cardiac deaths in forensic autopsies
    Das, Taner
    Bugra, Aytul
    Bugra, Abdul Kerim
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (02) : 937 - 944
  • [33] Cardiac evaluation in children with malnutrition
    Akdeniz, Osman
    Yilmaz, Erdal
    Celik, Muhittin
    Ozgun, Nezir
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2019, 54 (03): : 157 - 165
  • [34] Evaluation of histopathological findings of cardiac deaths in forensic autopsies
    Taner Daş
    Aytül Buğra
    Abdul Kerim Buğra
    Irish Journal of Medical Science (1971 -), 2022, 191 : 937 - 944
  • [35] Evaluation of cardiac function in pediatric patients diagnosed with mucopolysaccharidosis (MPS) and use of annular plane systolic excursion (APSE) to evaluate systolic function
    Ertas, Kerem
    Gul, Ozlem
    Bozaci, Ayse Ergul
    Bilgin, Huseyin
    MOLECULAR GENETICS AND METABOLISM, 2025, 144 (04)
  • [36] Giant lymphomatous cardiac mass: In vivo imaging and histological findings
    Gurunathan, Sothinathan
    Ahmed, Asrar
    Adel, Nayef
    Vamvakidou, Anastasia
    Karogiannis, Nikolaos
    Senior, Roxy
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 81 - 83
  • [37] The effect of neonatal gene therapy with a gamma retroviral vector on cardiac valve disease in mucopolysaccharidosis VII dogs after a decade
    Bigg, Paul W.
    Sleeper, Meg M.
    O'Donnell, Patricia A.
    Liu, Yuli
    Wu, Susan
    Casal, Margret L.
    Haskins, Mark E.
    Ponder, Katherine P.
    MOLECULAR GENETICS AND METABOLISM, 2013, 110 (03) : 311 - 318
  • [38] Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis
    Javed, Ahmed
    Aslam, Tariq
    Jones, Simon A.
    Ashworth, Jane
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (02) : 954 - 958
  • [39] iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II
    Hong, Junjie
    Cheng, Yu-Shan
    Yang, Shu
    Swaroop, Manju
    Xu, Miao
    Beers, Jeanette
    Zou, Jizhong
    Huang, Wenwei
    Marugan, Juan J.
    Cai, Xiujun
    Zheng, Wei
    EXPERIMENTAL CELL RESEARCH, 2022, 412 (01)
  • [40] Radiographic Findings of Mucopolysaccharidosis and Comparison With Bone Mineral Density: A Study from Southeastern Turkey
    Ayaz, Ercan
    Bozaci, Ayse Ergul
    JOURNAL OF CLINICAL DENSITOMETRY, 2022, 25 (04) : 475 - 484